Caitlin Cronin

Stock Analyst at Canaccord Genuity

(0.41)
# 2592
Out of 5,378 analysts
29
Total ratings
Success rate
Average return
12 Stocks
Name Action PT Current % Upside Ratings Updated
ENOV Enovis
Maintains: Buy
75 70
30 133.33% 2 May 14, 2025
AXGN Axogen
Maintains: Buy
26 24
9.77 145.65% 6 May 13, 2025
SNN Smith & Nephew
Maintains: Hold
27 28
29.16 -3.98% 2 May 1, 2025
INMD InMode
Maintains: Hold
17 15
13.49 11.19% 3 Apr 29, 2025
TELA TELA Bio
Maintains: Buy
12 7
1.73 304.62% 4 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 15
6.53 129.71% 1 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
64 67
41.66 60.83% 3 Feb 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
3 4
3.46 15.61% 2 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 20
10.86 84.16% 3 Aug 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
130
91.53 42.03% 1 Feb 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
79
57.82 36.63% 1 Feb 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
270 12
8 50% 1 Nov 14, 2023